Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
Actual shortage: | 7 (2%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 6 (2%) | |
Resolved: | 309 (96%) | |
Discontinuation Reports |
56 |
|
To be discontinued: | 2 (4%) | |
Discontinued: | 54 (96%) | |
Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2018-05-17 | 2018-11-30 | 49681 |
ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2019-02-08 | 2019-07-26 | 75189 |
BOOSTRIX-POLIO | 40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG | SUSPENSION | Resolved | 2017-08-18 | 2017-12-07 | 19888 |
BOOSTRIX-POLIO | 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF | SUSPENSION | Resolved | 2023-06-21 | 2023-10-04 | 196056 |
SYNFLORIX | 3MCG 3MCG 3MCG 1MCG 3MCG 1MCG 1MCG 1MCG 1MCG 1MCG 1MCG | SUSPENSION | Resolved | 2018-07-13 | 2018-08-02 | 55709 |
CERVARIX | 20MCG 20MCG | SUSPENSION | Resolved | 2018-04-13 | 2018-11-15 | 45668 |
BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-07-13 | 2018-08-08 | 55706 |
BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-08-31 | 2018-09-06 | 59702 |
BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2018-10-05 | 2018-10-31 | 63383 |
BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2019-02-13 | 2019-03-22 | 75721 |
BEXSERO | 50MCG 50MCG 50MCG 25MCG | SUSPENSION | Resolved | 2019-02-13 | 2019-03-21 | 75724 |
BEXSERO | 25MCG 50MCG 50MCG 50MCG | SUSPENSION | Resolved | 2024-01-12 | 2024-02-10 | 215839 |
SHINGRIX | 50MCG | SUSPENSION | Resolved | 2018-04-13 | 2018-06-08 | 45716 |
SHINGRIX | 50MCG | SUSPENSION | Resolved | 2018-08-24 | 2020-06-18 | 59142 |
SHINGRIX | 50MCG | SUSPENSION | Resolved | 2018-08-24 | 2020-06-18 | 59145 |
SHINGRIX | 50MCG | SUSPENSION | Resolved | 2022-03-17 | 2022-09-09 | 156847 |
SHINGRIX | 50MCG | SUSPENSION | Resolved | 2022-09-30 | 2022-10-13 | 170539 |
SHINGRIX | 50MCG | SUSPENSION | Resolved | 2023-06-08 | 2023-07-15 | 193889 |
SHINGRIX | 50MCG | SUSPENSION | Actual shortage | 2024-04-24 | 2024-04-25 | 226055 |
ENGERIX-B | 10MCG | SUSPENSION | Resolved | 2021-06-28 | 2021-07-20 | 141615 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |
AVANDAMET | 500MG 2MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8077 |
AVANDAMET | 1000MG 2.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8081 |
AVANDAMET | 1000MG 4.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8084 |
AVANDAMET | 500MG 4MG | TABLET | Discontinued | 2017-04-25 | 2017-05-04 | 8087 |
REQUIP | 0.25MG | TABLET | Discontinued | 2017-09-19 | 2017-11-01 | 22594 |
REQUIP | 1MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22597 |
REQUIP | 2MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22600 |
REQUIP | 5MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22603 |
ZANTAC | 150MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22611 |
ZANTAC | 300MG | TABLET | Discontinued | 2017-09-19 | 2017-09-19 | 22614 |
AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |
HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |